PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+40.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$484M
AUM Growth
+$67.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1 +$43.2M
2 +$35.9M
3 +$31M
4
VEEV icon
Veeva Systems
VEEV
+$23.9M
5
PHR icon
Phreesia
PHR
+$20.2M

Top Sells

1 +$21.8M
2 +$15.4M
3 +$14M
4
DXCM icon
DexCom
DXCM
+$13.1M
5
IMVT icon
Immunovant
IMVT
+$10.1M

Sector Composition

1 Healthcare 99.58%
2 Industrials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
26
Tectonic Therapeutic
TECX
$588M
$4.9M 1.01%
235,000
-144,254
CDNA icon
27
CareDx
CDNA
$1.18B
$4.71M 0.97%
250,000
-254,030
TERN
28
DELISTED
Terns Pharmaceuticals
TERN
$3.84M 0.79%
+95,000
RCKT icon
29
Rocket Pharmaceuticals
RCKT
$335M
$2.61M 0.54%
743,942
-524,023
KIDS icon
30
OrthoPediatrics
KIDS
$441M
$2.43M 0.5%
136,741
-171,966
OKUR
31
OnKure Therapeutics
OKUR
$170M
$2.37M 0.49%
816,909
+548,950
BBIO icon
32
BridgeBio Pharma
BBIO
$13B
$2.29M 0.47%
30,000
-234,500
ABVX
33
Abivax
ABVX
$10.6B
$2.29M 0.47%
+17,000
ACET icon
34
Adicet Bio
ACET
$87M
$2.11M 0.44%
+250,244
TEM
35
Tempus AI
TEM
$9.06B
$2.07M 0.43%
+35,000
TBI
36
Trueblue
TBI
$189M
$2.01M 0.42%
442,554
+363,078
PLRX icon
37
Pliant Therapeutics
PLRX
$78M
$1.9M 0.39%
1,555,744
+1,535,257
RNTX
38
Rein Therapeutics
RNTX
$94.9M
$513K 0.11%
442,600
-125,298
DXCM icon
39
DexCom
DXCM
$28.5B
-195,217
ACHC icon
40
Acadia Healthcare
ACHC
$2.13B
-250,000
ACTU
41
Actuate Therapeutics
ACTU
$48.3M
-885
CORT icon
42
Corcept Therapeutics
CORT
$7.46B
0
BHVN icon
43
Biohaven
BHVN
$1.66B
-600,000
ARGX icon
44
argenx
ARGX
$52B
-3,300
ALGN icon
45
Align Technology
ALGN
$12.5B
-19,442
AKRO
46
DELISTED
Akero Therapeutics
AKRO
-39,072
CTMX icon
47
CytomX Therapeutics
CTMX
$784M
-564,800
ISRG icon
48
Intuitive Surgical
ISRG
$150B
-48,711
PRTA icon
49
Prothena Corp
PRTA
$533M
-20,000
SDGR icon
50
Schrodinger
SDGR
$1.14B
-34,830